A rare genetic condition takes its name from the makeup worn in kabuki theatre
In short: Kabuki syndrome is a rare genetic condition first described in 1981 by two Japanese research groups. Its name comes from the resemblance of affected faces to the stage makeup of kabuki, a traditional Japanese theatre form. The condition touches many parts of the body, and its features and severity vary widely from person to person.
Kabuki syndrome affects roughly one in 32,000 births and is a rare inherited disorder with origins in genetics. Researchers led by Norio Niikawa and Yoshikazu Kuroki first described it in 1981. The most recognised sign is a distinctive face: long eyelids with lower lids that turn outward, arched and broad eyebrows, a flat nasal tip and prominent, low-set ears. These features become less obvious in later childhood. The condition can also bring short stature, heart defects, feeding difficulties, weak muscle tone, skeletal abnormalities and mild to moderate intellectual disability.
Two genetic forms are recognised. Type 1 traces to changes in the KMT2D gene, which account for about 75 percent of diagnoses according to the NHS Genomics Education resource, and follows an autosomal dominant pattern of inheritance. Type 2 traces to changes in the KDM6A gene, found in about 5 percent of diagnoses, and follows an X-linked dominant pattern. Both genes help regulate chromatin, the mix of proteins and DNA that packs genetic material into the cell nucleus, and so influence whether particular genes are switched on or off. When these genes are altered, the regulation of developmental genes is disrupted, though researchers do not yet know fully which developmental genes are affected.
Most cases arise from new changes that neither parent carried, and the majority are simplex, meaning only one family member is affected. Where neither parent carries the variant, the chance of recurrence in later pregnancies is said to be under one percent. Not everyone who carries a KMT2D variant develops the condition, a pattern called incomplete penetrance. Some people with the syndrome have no identifiable genetic cause, which may reflect changes that routine tests cannot detect, or other disorders that share features with it.
Diagnosis relies on international consensus criteria published in 2019, combining a history of infantile hypotonia, developmental delay or intellectual disability with a pathogenic variant or typical facial features. Care is usually delivered by a multidisciplinary team including clinical genetics, paediatrics, ophthalmology, audiology, endocrinology and cardiology. Because the features differ so much between individuals, the condition is best understood as a family of related presentations rather than one fixed profile.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Kabuki syndrome — Knowledge Hub
- Also: Kabuki syndrome
To cite this card, link to https://intellectplus.co.uk/app/health-kabuki-syndrome.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Medical history · More in Health · Latest · A–Z · All topics